Advances in Therapy

Omacor® (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia
pp. 675-690(16)
Author: Rupp, Heinz

Indacaterol, a novel inhaled, once-daily, long-acting beta₂-agonist for the treatment of obstructive airways diseases
pp. 691-699(9)
Authors: Beeh, Kai; Beier, Jutta

Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension
pp. 700-710(11)
Authors: Riccioni, Graziano; Vitulano, Nicola; D'Orazio, Nicolantonio; Bellocci, Fulvio

Dyslipidemia therapy update: the importance of full lipid profile assessment
pp. 711-718(8)
Authors: Menown, I.; Murtagh, G.; Maher, V.; Cooney, M.; Graham, I.; Tomkin, G.

Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial
pp. 719-727(9)
Authors: Busch, Regina; Graubaum, Hans-Joachim; Gruenwald, Joerg; Faergemann, Jan

Comparing hydrocortisone and methylprednisolone in patients with septic shock
pp. 728-735(8)
Authors: Yu, Teng-Jen; Liu, Yu-Chih; Yu, Chung-Chieh; Tseng, Jo-Chi; Hua, Chung-Ching; Wu, Huang-Pin

Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
pp. 736-736(1)
Authors: Tahrani, Abd; Piya, Milan; Barnett, Anthony

Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis
pp. 737-737(1)
Authors: Simpson, Kit; Welch, Mary; Kozel, F.; Demitrack, Mark; Nahas, Ziad